Journal profile · NANOSCIENCE & NANOTECHNOLOGY-MEDICINE, RESEARCH & EXPERIMENTAL
Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
ISSN 1939-5116 · eISSN 1939-0041 · Wiley-Blackwell · UNITED STATES · Bimonthly · Founded 2008
Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 8.52; hybrid open access; APC about USD 4,730; median 145 days to acceptance (80 articles, last 24 months); 59 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology is published by Wiley-Blackwell and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Nanoparticle-Based Drug Delivery, Nanoplatforms for cancer theranostics and Advanced biosensing and bioanalysis techniques, together about 38.1% of its articles. Its main subfields are Biomedical Engineering and Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
The Wiley Interdisciplinary Reviews (WIREs) series combines features of encyclopedic reference works and review journals. They are designed to serve as interdisciplinary resources across health, life, physical, and social science communities. Our goal is to help researchers save valuable time and stay current in their field and complementary fields with review articles that synthesize key findings from the growing number of primary research articles published daily.
From the journal's Aims & Scope
Research area (LetPub): NANOSCIENCE & NANOTECHNOLOGY-MEDICINE, RESEARCH & EXPERIMENTAL
Editor-in-chief Fabiana QuagliaPublisher website
Editorial board by country: 4 in mainland China (about 10%); most named United States 21, Mainland China 4, United Kingdom 3, South Korea 2, France 2 (40 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Nanoparticle-Based Drug DeliveryMaterials Science15.5%
- Nanoplatforms for cancer theranosticsEngineering12.6%
- Advanced biosensing and bioanalysis techniquesBiochemistry, Genetics and Molecular Biology9.9%
- RNA Interference and Gene DeliveryBiochemistry, Genetics and Molecular Biology9.1%
- Graphene and Nanomaterials ApplicationsEngineering6.1%
- Nanoparticles: synthesis and applicationsMaterials Science5.6%
- Gold and Silver Nanoparticles Synthesis and ApplicationsMaterials Science3.2%
- Biochemical and Structural CharacterizationBiochemistry, Genetics and Molecular Biology3.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Medicine, Research & Experimental | Zone 3 |
| Minor | Nanoscience & Nanotechnology | Zone 3 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Nanoscience & Nanotechnology | Zone 2 |
| Minor | Medicine, Research & Experimental | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Medicine, Research & Experimental | Zone 2 |
| Minor | Nanoscience & Nanotechnology | Zone 3 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPubMedINSPECCASPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 8.52LetPub ·
- Impact factor (publisher)
- 8.6Publisher website ·
- Impact factor (publisher) 2025
- 8.6Publisher website ·
- CiteScore 2026-06
- 19.8LetPub ·
- CiteScore (publisher)
- 19.8Publisher website ·
- CiteScore (publisher) 2025
- 19.8Publisher website ·
- SJR 2026-06
- 1.57LetPub ·
- SNIP 2026-06
- 1.37LetPub ·
- h-index
- 124OpenAlex ·
- i10-index
- 839OpenAlex ·
- 2-year mean citedness
- 9.99OpenAlex ·
- Self-citation rate
- 1.2%LetPub ·
- Share of gold OA articles
- 34.94%LetPub ·
Volume
- Articles per year
- 43LetPub ·
- Articles per year (publisher) 2025
- 43Publisher website ·
- Downloads per year (publisher) 2025
- 331,667Publisher website ·
Articles by year OpenAlex count · 1,231 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 37 | 22 | 29 |
| 2025 | 59 | 38 | 450 |
| 2024 | 88 | 50 | 1,359 |
| 2023 | 69 | 41 | 1,241 |
| 2022 | 110 | 45 | 3,571 |
| 2021 | 86 | 29 | 3,210 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
145 daysMedian, submission to acceptance · P25–P75 89 days – 224 days
- Acceptance to online
- median 20 days (80 articles)
- Submission to online
- median 171 days
- Sample
- 80 articles with submission and acceptance dates (101 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,730 / EUR 3,960 / GBP 3,140 | — | — | |
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Reference style
- APA
- Suggested reviewers
- Optional
- Graphical abstract
- Required
- Not considered
- LaTeX template
Article types accepted8
- advanced reviewADVANCED REVIEW Aimed at researchers and advanced students with a strong background in the subject.Length not stated
- focus articleFOCUS ARTICLE These articles are mini-reviews focusing on a particular concept, example, application, region, method, debate, etc., and which therefore illustra…Length not stated
- overviewOVERVIEW Broad and relatively non-technical treatment of important topics at a level suitable for advanced students and for researchers without a strong backgro…Length not stated
- perspectivePERSPECTIVE A forum for thought-leaders, hand-picked by the editors, to provide a more individual perspective on the field in question or to set out new agendas…Length not stated
- primerPRIMER Meant to be understood by a very general audience, such as undergraduates just entering a given field.Length not stated
- software focusSOFTWARE FOCUS Used to describe specific software packages of high utility in a certain field.Length not stated
- systematic reviewSYSTEMATIC REVIEW A subset of Advanced Reviews that address key questions on crucial issues through evidence-based narrative syntheses of peer-reviewed literatu…Length not stated
- updateUPDATE Part of the encyclopedic aspect of WIREs is the ability for authors to update their articles to include new findings or references.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Data availability, Publication ethics, License & copyright, Open access, Peer review, Self-archiving
- AI use
AI tools cannot be authors; use must be disclosed in Methods or Acknowledgements. Model summary
If an author has used this kind of tool to develop any portion of a manuscript, its use must be described, transparently and in detail, in the Methods or Acknowledgements section.
Source ↗Publisher website ·- Authorship
CRediT author contributions required at submission. Model summary
This journal requires details of all authors’ contributions to the work by filling out CRediT (Contribution Roles Taxonomy) information during submission.
Source ↗Publisher website ·- Data availability
Data sharing encouraged; data availability statement may be provided. Model summary
Wiley encourages authors to share their research data by archiving it in an appropriate public repository. Authors may provide a data availability statement, including a link to the repository they have used, to be included in their article.
Source ↗Publisher website ·- Publication ethics Publication Ethics and Malpractice Statement
Publication Ethics and Malpractice Statement: adherence to COPE Core Practices; misconduct results in rejection/retraction. Model summary
The WIREs adhere strongly to the Core Practices of the Committee on Publication Ethics (COPE). All instances of publishing misconduct, including, but not limited to, plagiarism, data fabrication, image/data manipulation to falsify/enhance results, etc. will result in rejection/retraction of the manuscript in question.
Source ↗Publisher website ·- License & copyright Open Access Licensing and Copyright
Open Access articles are published under the terms of the Creative Commons Attribution License. The CC-BY license permits commercial and non-commercial re-use of an open access article, as long as the author is properly attributed. WIREs journals offer CC BY, CC BY-NC, and CC BY-NC-ND licensing options.
Source ↗Publisher website ·- Open access Gold Open Access
Open access licensing: CC BY, CC BY-NC, CC BY-NC-ND options. Model summary
WIREs journals offer authors the chance to publish their articles open access: immediately freely available to read, download, and share. Read More Article Publication Charges For article publication charges (APCs) please see the 'Open Access' section in the 'About' tab of each individual journal. Authors who receive funding from an agency or institution with a Wiley Open Access Account do not pay…
Source ↗Publisher website ·- Peer review Peer Review
WIREs is participating in a pilot of the NISO Working Group on Peer Review Terminology. Standardizing the terminology across journals and publishers used to describe peer review practices helps make the peer review process for articles and journals more transparent, and it will enable the community to better assess and compare peer review practices between different journals. More Information Taxo…
Source ↗Publisher website ·- Self-archiving Green Open Access
PubMed Central embargo of 12 months after publication for NIH-funded authors. Model summary
PubMed Central For authors who are funded by the NIH or a PMC/Europe PMC partner and have indicated so during submission, Wiley will deposit the manuscript to the NIH Manuscript System upon publication. Authors should receive an email from NIHMS with instructions on completing the system checks before the article is assigned a PMCID. (If not, authors can email the production editor to obtain the N…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2008
- ISSN
- 1939-5116
- Electronic ISSN
- 1939-0041
- Latest issue on the website
- Volume 18, Issue 5 (October 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
What CAS zone is Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology is in Zone 2 of Medicine, and in Zone 3 of the minor category Medicine, Research & Experimental / Nanoscience & Nanotechnology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology?
The latest impact factor listed by LetPub is 8.52; CiteScore 19.8, h-index 124.
How long does peer review take at Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology?
Based on the dates recorded on 80 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 145 days (interquartile range 89–224 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology?
According to the journal's author guidelines: Reference style: APA; Suggested reviewers: Optional; Graphical abstract: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology based?
Of the 40 board members whose country the journal's board page names, 4 (about 10%) are in mainland China; the countries named most often are United States (21), Mainland China (4) and United Kingdom (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology?
According to LetPub and DOAJ records, Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology is indexed in SCIE and Scopus. The journal's website also lists Web of Science, MEDLINE, PubMed, INSPEC and CAS; that list has not been checked against each database.
Is Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology open access, and what is the APC?
Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology is a hybrid journal. For open-access publication: APC about USD 4,730.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .